Leading Edge Technology for Pathogen Detection
As Seen In:
Leading-Edge Technologies to Detect Aerosolized Pathogens
- Signed Options Agreement: Technology developed by WashU that immediately detects SARS-CoV-2 and other pathogens in people and spaces
- Funded research: Through NIH RADx Initiative Grant
- Purpose: Create biosensors that substantially reduce large-scale infectious disease testing times, and costs, and improve aerosolized pathogen detection sensitivity and specificity. Create biodetector devices which are inexpensive, easy to operate, and provide results in under 60 seconds with the accuracy of qPCR.
The scientific journal ACS Sensors published a report by Y2X Life Science’s academic collaborators entitled “Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath…
Y2X Life Sciences’ academic collaborators at Washington University in St. Louis published a piece in the scientific journal Nature Communications called "Real-time environmental surveillance…
Y2X Life Sciences actively engages in groundbreaking research and development for disrupting the transmission of infectious diseases.
The result is innovative technologies that bring about faster recoveries from pandemics like Covid-19, and have the potential to limit the scope and spread of future pandemics and epidemics.